Morgan Stanley Kiromic Biopharma, Inc. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.16 - $0.3 $0 - $1	6 Added 0.5%	1,206 $0
Q2 2022 Oct 27, 2022	SELL	$0.26 - $0.87 $1 - $4	-5 Reduced 0.41%	1,200 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.87 $1 - $4	-5 Reduced 0.41%	1,200 $1,000
Q1 2022 Oct 27, 2022	BUY	$0.6 - $1.82 $3 - $9	5 Added 0.42%	1,205 $1,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.82 $2 - $7	4 Added 0.33%	1,205 $1,000

Q4 2021 Feb 14, 2022	BUY	$1.53 - $3.12 $1 - $3	1 Added 0.08%	1,201 $2,000
Q3 2021 Nov 15, 2021	BUY	$2.69 - $4.94 $3,228 - $5,928	1,200 New	1,200 $4,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $34.7M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.